Job Description
Senior Director, Cytogenetics San Juan Capistrano, CA
Recognized by FORTUNE magazine as one of the Worlds Most Admired Companies, Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that doctors and patients need to make better healthcare decisions. They are pioneers in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
With corporate headquarters in Secaucus, NJ, Quest Diagnostics is a Fortune 500 company traded on the New York Stock Exchange (NYSE: DGX) and included in the Dow Jones Sustainability World Index. With 2019 revenues of $7.7 Billion and approximately 46,000 employees and 6,600 patient locations across the US, Quest Diagnostics serves half of the physicians and hospitals in the US with their large variety of products and services.
The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics also provides services to employers, life insurance companies, other commercial labs, clinics, health plans, government agencies, and organizations involved in clinical trials research.
Approximately 150 million times each year, patients and their physicians rely upon Quest Diagnostics results to make important healthcare decisions and approximately one third of U.S. physicians and many of the countrys leading hospitals and health systems relies on Quest Diagnostics healthcare information solutions to foster better patient care and outcomes.
Awards/Recognitions
FORTUNE magazine's World's Most Admired Companies list for 6 consecutive years; one of only five companies to attain Most Admired status in the Health Care, Pharmacy and Other Services industry category.
Fortune magazines Fortune 500 list
Forbes Global 2000
Forbes' America's Best Employers List for third consecutive year
Forbes 2019 Americas Best Employers for Women
S&P; 500
Barrons 500
Member of the Dow Jones Sustainability World Index
Listed in the most recent Newsweek Green Rankings
Consistently named one of the best places to work in U.S. business journal rankings
Named a DiversityInc Noteworthy Company for third consecutive year
Listed on the Disability Equality Index (DEI), a joint initiative of the American Association of People with Disabilities (AAPD) and the US Business Leadership Network (USBLN), recognizing companies for prioritizing the inclusion of people with disabilities
Named Top 23 Best Places to Work for LGBTQ Equality in New Jersey
Diagnostic Testing Services
Quest Diagnostics is the worlds leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Their services range from routine blood tests such as total cholesterol, Pap testing and white blood cell count to complex, gene-based and molecular testing. They perform medical tests that aid in the diagnosis or detection of diseases, measure the progress or recovery from a disease or confirm that an individual is free from disease. In addition, they have specialized expertise in cancer, cardiovascular diseases, infectious diseases, and neurology.
Outlook
In the $60 Billion and growing US Diagnostic Testing Market, Quest Diagnostics is the leader. Quest Diagnostics reputation as a leading innovator, provider of high value, low cost solutions and its financial strength and flexibility make it well positioned to capitalize on the evolving healthcare landscape.
Quest Diagnostics long-term strategy is to become the undisputed world leader in diagnostic testing, information and services. To drive this profitable growth, Quest Diagnostics plans to leverage capabilities to create differentiation:
Deliver Innovative Solutions
Leverage their Unparalleled Access and Distribution Network
Expand their relationships with large payors and health systems
Deliver Superior Patient Experiences
Position Description
The Senior Director, Cytogenetics is responsible for providing interpretation of cytogenetics/FISH results and providing consultation to the clinical laboratory within her/his area(s) of expertise which will maximize quality patient care and ensure continuous business growth throughout the Quest Diagnostics Nichols Institute family of laboratories.
Core Responsibilities
Scientific: Reviews, interprets, and documents clinical test results within established turnaround times.
Collaborates professionally with Laboratory manager, supervisors, technologists and other laboratory operations staff.
Due to the importance of quality patient care, servicing consultation requests of all types is considered imperative (assists treating physician).
Provides inputs and recommendations for developing new assays and potential research projects.
Significant collaboration with internal teams as it relates to testing menu, test selection and validation.
Educational Components:
Participates in educational programs of the Company.
Attendance at National meetings in areas of assigned expertise to maintain/build knowledge and to provide representation for Quest Diagnostics, Nichols Institute. Assists the delegate Clinical Consultant or Technical Supervisor in the responsibilities in Cytogenetics Specialty as delegated by the Laboratory Director Responsibilities.
Policy Components:
Collaborates in reviewing test method selection and validation.
Collaborates in ensuring that the proficiency testing program is conducted in a timely manner, reviewed by appropriate staff, and approve of corrective action when a proficiency testing result is found to be unsatisfactory.
Collaborates in monitoring quality control to ensure that acceptable levels of analytical performance are maintained for each test system. Ensure that patient test results are reported only when the system is functioning properly.
Collaborates in corrective action and preventative action plans and procedures.
Collaborates in the annual review of Standard Operating Procedures for test systems.
Collaborates in reviews of report format for appropriateness of clinical information communicated in areas of assigned expertise. Collaborates in review of interpretative reporting comments as needed.
Qualifications
Educational:
MD, PhD Degree or equivalent.
Board Certified in Clinical Cytogenetics and Board Certified/Eligible in Molecular Genetics, or Board Certified in Laboratory Genetics and Genomics by ABMGG, and California, and New York Licensed/eligible.
Work Experience:
A minimum of 3 years of practical experience in a clinical cytogenetics laboratory.
Skills/experience in medical publications is desired.
Chromosomal microarray analysis and reporting experience is a must.
Special Requirements:
All Cytogenetics Directors should be prepared to demonstrate competence in their fields of practice. Cytogenetics Directors should exemplify professionalism consistent with Quest Diagnostics Nichols Institute's values, vision, mission and fundamental objectives.
To Apply
Please Log In or Register to Upload a Resume and complete the online Application by visiting questdiagnostics.com/careers, clicking Job Search and following the prompts. Because of the large number of applicants to job openings, Quest Diagnostics will only contact qualified candidates for interviews.
Quest Diagnostics is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veterans or disability status.
Secaucus, NJ
Company Overview
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
At a Glance
Quest Diagnostics is the world’s leading provider of diagnostic information services
Generated 2018 revenues of approximately $7.53 billion
Publicly trades common stock on the New York Stock Exchange (NYSE: DGX). More in Investor Relations
Ranks as a component of the S&P 500
Touches the lives of 30 percent of American adults each year
Serves about half of the physicians and hospitals in the U.S
Access to approximately 90% of U.S. insured lives
Engages workforce of about 46,000 employees dedicated to putting patients first every day
More than 6,600 patient access points, the most extensive network in the U.S.,
including phlebotomists in physician offices and more than 2,250 of our own
patient service centers
A medical and scientific staff of more than 600 M.D.s and Ph.D.s
Logistics capabilities, that include approximately 3,750 courier vehicles and 25 aircraft that collectively make tens of thousands of stops daily
Offers physicians a test menu that is industry leading in breadth and innovation. Our test menu ranges from routine biological tests to complex and specialized molecular and gene-based testing as well as anatomic pathology
Provides a broad range of solutions for employers, including workplace drug testing for employers and government agencies; the Blueprint for Wellness employee wellness service; and risk assessment services for the life insurance industry
Publishes original research in peer reviewed publications, at medical and scientific conferences, and as a public service. Quest Diagnostics Health Trends reports examine trends in diseases based on the company’s United States database. Quest Diagnostics Drug Testing Index (DTI) reports examine trends in workplace drug testing, and have been considered a benchmark for U.S. workforce drug positivity trends since 1988
Recognition
Named to Fortune Magazine's 2019 World's Most Admired Companies list in the Health Care industry category of "Pharmacy and Other Services" for the third consecutive year
Among FORTUNE® Magazine's 2018 Fortune 500® companies
Ranked on the Forbes® 2018 Global 2000
Ranked on the “Barron’s 500” list of top-performing large companies for 2017
Named a member of the Dow Jones® Sustainability World and North America indexes since 2004 (DJSI World) and 2005 (DJSI North America). The Dow Jones Sustainability World Index represents the top 10% of the leading sustainability companies out of the biggest 2,500 companies in the Dow Jones Global Total Stock Market Index
Earned a place on the annual Newsweek Green Rankings, for the fourth consecutive year on the 2017 U.S. list
Consistently named one of the best places to work in U.S. business journal rankings, including Forbes® 2018 America's Best Large Employers
Achieved Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer, recognizing our important actions to reduce the cancer risk of employees and their families
Received a rating of 100 from the Human Rights Campaign on the 2018 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBT Equality"
Named a DiversityInc Noteworthy Company for the second consecutive year in 2018
Read more about awards and honors.
Read more about our Reputation Honors and Corporate Social Responsibility programs.
Products and Services
Diagnostics information services
Clinical trials
Healthcare IT
Wellness & risk management
Drug Screening
Read more about products and services.
Operations
Headquarters in the U.S.: 500 Plaza Drive, Secaucus, New Jersey 07094
Approximately 2,200 patient locations and dozens of clinical laboratories throughout the U.S.
In addition to the U.S., Quest Diagnostics operates clinical laboratories in laboratory facilities in Gurgaon, India; Heston, England; Mexico City, Mexico; and San Juan, Puerto Rico